+Compare
WDNA
ETF ticker: BATS
AS OF
Loading...
Price
Loading...
Change
Loading...
Net Assets
2.51M

WDNA WisdomTree BioRevolution ETF Forecast, Technical & Fundamental Analysis

Category Health
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for WDNA with price predictions
08:00 PM EDT Sep 19, 2023

WDNA sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for WDNA moved below the 200-day moving average on August 22, 2023. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 11, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on WDNA as a result. In of 38 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for WDNA turned negative on September 18, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 17 similar instances when the indicator turned negative. In of the 17 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WDNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for WDNA entered a downward trend on September 19, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WDNA advanced for three days, in of 131 cases, the price rose further within the following month. The odds of a continued upward trend are .

WDNA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), ZOETIS (NYSE:ZTS), Archer Daniels Midland Company (NYSE:ADM).

Industry description

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“index”). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

Market Cap

The average market capitalization across the WisdomTree BioRevolution ETF ETF is 49.16B. The market cap for tickers in the group ranges from 64.65K to 540.76B. LLY holds the highest valuation in this group at 540.76B. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the WisdomTree BioRevolution ETF ETF was -4%. For the same ETF, the average monthly price growth was -5%, and the average quarterly price growth was -6%. MYGN experienced the highest price growth at 6%, while BHIL experienced the biggest fall at -39%.

Volume

The average weekly volume growth across all stocks in the WisdomTree BioRevolution ETF ETF was -25%. For the same stocks of the ETF, the average monthly volume growth was -53% and the average quarterly volume growth was -1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 66
Price Growth Rating: 59
SMR Rating: 74
Profit Risk Rating: 71
Seasonality Score: -35 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
WisdomTree Trust380 Madison AveNew York
Phone
866-909-9473
Web
www.wisdomtree.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIG62.32-0.04
-0.06%
American International Group
MMYT37.34-0.19
-0.51%
MakeMyTrip Limited
CRBP6.76-0.15
-2.17%
Corbus Pharmaceuticals Holdings
PCYO9.66-0.24
-2.42%
Pure Cycle Corp
CUBI32.38-0.84
-2.53%
Customers Bancorp

WDNA and

Correlation & Price change

A.I.dvisor tells us that WDNA and XBI have been poorly correlated (+-0% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WDNA and XBI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WDNA
1D Price
Change %
WDNA100%
-0.83%
XBI - WDNA
-0%
Poorly correlated
-2.17%
IBB - WDNA
-3%
Poorly correlated
-0.86%
VHT - WDNA
-4%
Poorly correlated
-0.09%
IHI - WDNA
-5%
Poorly correlated
-1.03%
XLV - WDNA
-5%
Poorly correlated
+0.01%